[Treatment of 5 patients affected by Kaposi's sarcoma and AIDS with recombinant interferon alfa-2A (roferon-A)] NLM AIDSLINE Important note: Information in this article was accurate in 1990. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[Treatment of 5 patients affected by Kaposi's sarcoma and AIDS with recombinant interferon alfa-2A (roferon-A)]

Med Cutan Ibero Lat Am. 1989;17(4):269-73. Unique Identifier : AIDSLINE MED/90135520
Lopez Bran E; Aguilar R; Marron JA; Figueredo MA; Garcia Ruiz JM; Departamento de Dermatologia Medico-Quirurgica y; Venereologia, Hospital Universitario San Carlos, Madrid.

Abstract: alpha-2A-interferon is a useful and safe drug in Kaposi's sarcoma treatment although not free of serious side-effects when used at therapeutic dosages by which strict controls must be undertaken. When treatment has been interrupted, worsening and dissemination of the disease happened. No correlation has been found between immunologic parameters and the treatment used.
Keywords: Acquired Immunodeficiency Syndrome/COMPLICATIONS/*THERAPY English Abstract Human Interferon Alfa-2a/*THERAPEUTIC USE Interferon Alfa, Recombinant/*THERAPEUTIC USE Male Sarcoma, Kaposi's/COMPLICATIONS/*THERAPY JOURNAL ARTICLEKWDacquiredimmunodeficiencysyndrome/complications/KWDtherapyenglishabstracthumaninterferonalfa-2a/KWDtherapeuticuseinterferonalfa,recombinant/KWDtherapeuticusemalesarcoma,kaposi's/complications/KWDtherapyjournalarticle
900530
M9050726

Copyright © 1990 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1990. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1990. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .